Procedures for monitoring recombinant erythropoietin and analogs in doping.

Détails

ID Serval
serval:BIB_41BBD7A76C89
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Procedures for monitoring recombinant erythropoietin and analogs in doping.
Périodique
Endocrinology and Metabolism Clinics of North America
Auteur(s)
Lamon S., Robinson N., Saugy M.
ISSN
1558-4410[electronic], 0889-8529[linking]
Statut éditorial
Publié
Date de publication
2010
Volume
39
Numéro
1
Pages
141-54, x
Langue
anglais
Résumé
Hemoglobin concentration is one of the principal factors of aerobic power and, consequently, of performance in many types of physical activities. The use of recombinant human erythropoietin is, therefore, particularly powerful for improving the physical performances of patients, and, more generally, improving their quality of life. This article discusses procedures for monitoring recombinant erythropoietin and its analogues in doping for athletic performance.
Mots-clé
Athletic Performance/physiology, Doping in Sports/history, Doping in Sports/prevention & control, Erythropoietin, Recombinant/administration & dosage, Erythropoietin, Recombinant/analysis, False Positive Reactions, Hematocrit, Hemoglobins/analysis, History, 20th Century, History, 21st Century, Humans, Immunoassay, Isoelectric Focusing/standards, Oxygen Consumption/drug effects
Pubmed
Web of science
Création de la notice
08/11/2010 17:15
Dernière modification de la notice
03/03/2018 16:34
Données d'usage